The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

PDL BioPharma

  • PDLI
  • NASDAQ
  • Consumer Products
  • Latest 7.63
  • Currency US$
  • Change -0.01
  • Percent Change -0.131 %
  • Volume 1,716,673
  • Tue Sep 23, 2014 02:08 PM EDT NASDAQ data delayed 15 minutes.
  • Open 7.60
  • Previous Close 7.64
  • High 7.66
  • Low 7.52
  • Bidx13 7.62
  • Askx39 7.63
  • 52-week High09/02 10.26
  • 52-week Low02/05 7.38
  • Beta 0.637
  • Market Cap 1,223.47M
  • EPS 1.71
  • P/E 4.462
  • Forward P/E
  • PEG
  • Annual Dividend 0.60
  • Yield 7.864

News

Financials & Calendars

Income Statement

  • Sales $490,730,000
  • Earnings $283,930,000
  • Return on Equity 179.88%

Cash Flow

  • Cash Flow --
  • Cash $334,030,000
  • Current Ratio 1.03

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $852,570,000
  • Liabilities $650,360,000
  • Liabilities-to-Equity Ratio 3.22

Price Ratios

  • Price to Sales 2.49
  • Price to Book 6.05
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Aug 11 $0.55 Nov 5 $0.71
Surprises Aug 11 -5.45% n/a n/a
Dividends Sep 3 $0.15 Dec 3 $0.15
Splits n/a -- n/a n/a

12 months ended Sep 23, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.

Related Securities
Symbol Type Latest % Chg

Officers

  • John P. McLaughlin President and Chief Executive
  • Peter S. Garcia Vice President and Chief Finan
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

932 SOUTHWOOD BLVD
INCLINE VILLAGE, NV
89451

Phone: (775)-832-8500
Fax: (775)-8328501


www.pdl.com

Ideas & Discussion

Live Discussion of PDLI on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.